+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Lipid Disorder Treatment Market - Global Industry Analysis, Share, Size, Growth, Trends and Forecast 2017-2026

  • ID: 4851223
  • Report
  • March 2018
  • Region: Global
  • 170 pages
  • Transparency Market Research
1 of 2

This research report on global lipid disorders treatment market depicts the current as well as future scenario of various drugs used to treat lipid disorders. The research study includes analysis on key developments that are shaping the demand for advanced drugs for lipid disorders. A detailed qualitative assessment has been covered in this research report that delivers value by offering weighted analysis on restraints, drivers, trends and opportunities in the global market. Readers of the report can benefit from the actionable intelligence provided in this research report that is likely to impact the growth of the global market in the coming years.

An in-depth market assessment on the cost structure of various drugs used in the treatment of lipid disorders, detailed supply chain analysis, analysis on sourcing of raw material and various service providers has been covered for the reader’s perusal. Such an intense market analysis can support the reader’s decision in making expansion plans, implementing key strategies as well as tapping new regional markets and developing new products. Moreover, scrutiny on various lipid disorder treatments also covers the supply and demand scenario at a global level. The reader of the report can expect a high level analysis on major market aspects impacting the consumption and sales of several lipid disorder treating drugs.

Market Segmentation

Region

Drug Type

Distribution Channel

Indication

North America

Atorvastatin

Retail Pharmacies

Familial Combined Hyperlipidemia

Latin America

Fluvastatin

Hospital Pharmacies

Familial Defective Apolipoprotein B-100

Europe

Rosuvastatin

Online Pharmacies

Familial Dysbetalipoproteinemia

Japan

Simvastatin

Familial Hypertriglyceridemia

APEJ

Pravastatin

Heterozygous Familial Hypercholesterolemia

MEA

Other Drugs

Other Indications

 Detailed market segmentation carried out on this market covers every angle offering the readers with insights associated with sluggish or lucrative growth avenues. Detailed segment wise analysis offers the readers with market intelligence that can be used to distinguish between high growing, moderate growing and slow growing regions. New revenue pockets can be identified through the analysis done in this research report. The research study analyzes each and every segment of the market across key regions in the globe to portray a complete market understanding for a forecast period of nine years. The research study also covers historical data and current market scenario.

Competitive landscape

The research study on global lipid disorders treatment market includes a comprehensive competitive assessment that offers key insights on major pharmaceutical companies involved in the manufacturing of drugs for treating lipid disorders. Business strategies, market entry strategies, product portfolios of these key players has been covered in this research report. A complete market intelligence package is promised by including the section on competitive dashboard that tracks the activities of various companies, thus assisting the reader in sating key tactics to gain competitive advantage in the years to come. Additionally, key financials, revenue shares and profit analysis across range of products is included in this section. This information can assist the readers in analyzing weaknesses, threats, opportunities and strengths in the market.

The information on various segments, regions and competitors covered in this research report has been compiled using extensive secondary and in depth primary research modules. Moreover, investor and press releases, trade associations and industry databases have been churned to gather additional information thus presenting a portraying a complete market scenario. The process carried out during research ensures a high accuracy data and statistics, thus increasing the credibility of the research study.

Key Facts

Readers can benefit from the comprehensive 360 degree market outlook that covers key insights of the global market along with future market projections. Additionally, the research report can support upcoming businesses in gaining hold in the global market by identifying revenue pockets across the globe. Moreover, the systematic report structure and skilful statistical presentations make this research report user friendly and the analysis and insights can be used to formulate business strategies.

Note: Product cover images may vary from those shown
2 of 2
1. Global Outlook

2. Global Lipid Disorder Treatment Market - Executive Summary

3. Global Lipid Disorder Treatment Market Overview
3.1. Introduction
3.1.1. Global Lipid Disorder Treatment Market Taxonomy
3.1.2. Global Lipid Disorder Treatment Market Definition
3.2. Global Lipid Disorder Treatment Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Lipid Disorder Treatment Market Y-o-Y Growth
3.3. Global Lipid Disorder Treatment Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Porte's Five Forces Analysis
3.7. Desirable Lipid Levels in Adults
3.8. Limiting Fat and Cholesterol in the Diet
3.9. A Practical Approach to a Low-Cholesterol, Low-Saturated Fat Diet
3.10. Cholesterol and Heart Disease By the Numbers
3.11. Screening for Elevated Cholesterol
3.12. Lifestyle Interventions
3.13. Treatment based on Group
3.14. PEST Analysis
3.15. Market Positioning and Behaviour Assessment
3.16. Investment Feasibility Index
3.17. Competitor Market Footprint Matrix
3.18. Key Participants Market Presence (Intensity Map) By Region

4. Global Lipid Disorder Treatment Market Analysis and Forecast 2012-2026
4.1. Global Lipid Disorder Treatment Market Size and Forecast By Drug Type, 2012-2026
4.1.1. Atorvastatin Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Fluvastatin Market Size and Forecast, 2012-2026
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Rosuvastatin Market Size and Forecast, 2012-2026
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. Simvastatin Market Size and Forecast, 2012-2026
4.1.4.1. Revenue (US$ Mn) Comparison, By Region
4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region
4.1.5. Pravastatin Market Size and Forecast, 2012-2026
4.1.5.1. Revenue (US$ Mn) Comparison, By Region
4.1.5.2. Market Share Comparison, By Region
4.1.5.3. Y-o-Y growth Comparison, By Region
4.1.6. Other Drugs Market Size and Forecast, 2012-2026
4.1.6.1. Revenue (US$ Mn) Comparison, By Region
4.1.6.2. Market Share Comparison, By Region
4.1.6.3. Y-o-Y growth Comparison, By Region
4.2. Global Lipid Disorder Treatment Market Size and Forecast By Distribution Channel, 2012-2026
4.2.1. Retail Pharmacies Market Size and Forecast, 2012-2026
4.2.1.1. Revenue (US$ Mn) Comparison, By Region
4.2.1.2. Market Share Comparison, By Region
4.2.1.3. Y-o-Y growth Comparison, By Region
4.2.2. Hospital Pharmacies Market Size and Forecast, 2012-2026
4.2.2.1. Revenue (US$ Mn) Comparison, By Region
4.2.2.2. Market Share Comparison, By Region
4.2.2.3. Y-o-Y growth Comparison, By Region
4.2.3. Online Pharmacies Market Size and Forecast, 2012-2026
4.2.3.1. Revenue (US$ Mn) Comparison, By Region
4.2.3.2. Market Share Comparison, By Region
4.2.3.3. Y-o-Y growth Comparison, By Region
4.3. Global Lipid Disorder Treatment Market Size and Forecast By Indication, 2012-2026
4.3.1. Familial Combined Hyperlipidemia Market Size and Forecast, 2012-2026
4.3.1.1. Revenue (US$ Mn) Comparison, By Region
4.3.1.2. Market Share Comparison, By Region
4.3.1.3. Y-o-Y growth Comparison, By Region
4.3.2. Familial Defective Apolipoprotein B-100 Market Size and Forecast, 2012-2026
4.3.2.1. Revenue (US$ Mn) Comparison, By Region
4.3.2.2. Market Share Comparison, By Region
4.3.2.3. Y-o-Y growth Comparison, By Region
4.3.3. Familial Dysbetalipoproteinemia Market Size and Forecast, 2012-2026
4.3.3.1. Revenue (US$ Mn) Comparison, By Region
4.3.3.2. Market Share Comparison, By Region
4.3.3.3. Y-o-Y growth Comparison, By Region
4.3.4. Familial Hypertriglyceridemia Market Size and Forecast, 2012-2026
4.3.4.1. Revenue (US$ Mn) Comparison, By Region
4.3.4.2. Market Share Comparison, By Region
4.3.4.3. Y-o-Y growth Comparison, By Region
4.3.5. Heterozygous Familial Hypercholesterolemia Market Size and Forecast, 2012-2026
4.3.5.1. Revenue (US$ Mn) Comparison, By Region
4.3.5.2. Market Share Comparison, By Region
4.3.5.3. Y-o-Y growth Comparison, By Region
4.3.6. Other Indications Market Size and Forecast, 2012-2026
4.3.6.1. Revenue (US$ Mn) Comparison, By Region
4.3.6.2. Market Share Comparison, By Region
4.3.6.3. Y-o-Y growth Comparison, By Region

5. North America Lipid Disorder Treatment Market Size and Forecast, 2012-2026
5.1. North America Outlook
5.2. North America Parent Market Outlook
5.3. North America Target Market Outlook
5.4. Revenue (US$ Mn) Comparison, By Country
5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Drug Type
5.6. Revenue (US$ Mn) Comparison, By Distribution Channel
5.7. Revenue (US$ Mn) Comparison, By Indication

6. Latin America Lipid Disorder Treatment Market Size and Forecast, 2012-2026
6.1. Latin America Outlook
6.2. Latin America Parent Market Outlook
6.3. Latin America Target Market Outlook
6.4. Revenue (US$ Mn) Comparison, By Country
6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Drug Type
6.6. Revenue (US$ Mn) Comparison, By Distribution Channel
6.7. Revenue (US$ Mn) Comparison, By Indication

7. Europe Lipid Disorder Treatment Market Size and Forecast, 2012-2026
7.1. Europe Outlook
7.2. Europe Parent Market Outlook
7.3. Europe Target Market Outlook
7.4. Revenue (US$ Mn) Comparison, By Country
7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Drug Type
7.6. Revenue (US$ Mn) Comparison, By Distribution Channel
7.7. Revenue (US$ Mn) Comparison, By Indication

8. Japan Lipid Disorder Treatment Market Size and Forecast, 2012-2026
8.1. Japan Outlook
8.2. Japan Parent Market Outlook
8.3. Japan Target Market Outlook
8.4. Japan Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Drug Type
8.6. Revenue (US$ Mn) Comparison, By Distribution Channel
8.7. Revenue (US$ Mn) Comparison, By Indication

9. APEJ Lipid Disorder Treatment Market Size and Forecast, 2012-2026
9.1. APEJ Outlook
9.2. APEJ Parent Market Outlook
9.3. APEJ Target Market Outlook
9.4. Revenue (US$ Mn) Comparison, By Country
9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Drug Type
9.6. Revenue (US$ Mn) Comparison, By Distribution Channel
9.7. Revenue (US$ Mn) Comparison, By Indication

10. MEA Lipid Disorder Treatment Market Size and Forecast, 2012-2026
10.1. MEA Outlook
10.2. MEA Parent Market Outlook
10.3. MEA Target Market Outlook
10.4. Revenue (US$ Mn) Comparison, By Country
10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
10.4.3. Nigeria Market Size and Forecast (US$ Mn), 2012-2026
10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
10.5. Revenue (US$ Mn) Comparison, By Drug Type
10.6. Revenue (US$ Mn) Comparison, By Distribution Channel
10.7. Revenue (US$ Mn) Comparison, By Indication

11. Global Lipid Disorder Treatment Market Company Share, Competition Landscape and Company Profiles
11.1. Global Lipid Disorder Treatment Market Company Share Analysis
11.2. Global Lipid Disorder Treatment Market Competition Landscape
11.3. Global Lipid Disorder Treatment Market Company Profiles
11.3.1. Pfizer, Inc
11.3.2. Novartis AG
11.3.3. Astrazeneca Plc
11.3.4. Merck & Co.
11.3.5. Emcure Pharmaceuticals Ltd.
11.3.6. Ranbaxy Laboratories Ltd.
11.3.7. Teva Pharmaceuticals
11.3.8. Mylan Pharmaceuticals, Inc.
11.3.9. Kowa Pharmaceuticals America, Inc.
11.3.10. Glenmark Pharmaceuticals Ltd.
11.3.11. Sun Pharmaceuticals Industries Ltd.
11.3.12. Wockhardt Limited

12. Key Takeaways

13. Research Methodology

14. Disclaimer
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll